Your browser doesn't support javascript.
loading
Development of Resistance-Associated Mutations After Sotrovimab Administration in High-risk Individuals Infected With the SARS-CoV-2 Omicron Variant.
Birnie, Emma; Biemond, Jason J; Appelman, Brent; de Bree, Godelieve J; Jonges, Marcel; Welkers, Matthijs R A; Wiersinga, W Joost.
Afiliação
  • Birnie E; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Biemond JJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Appelman B; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • de Bree GJ; Division of Infectious Diseases, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Jonges M; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Welkers MRA; Department of Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
  • Wiersinga WJ; Center for Experimental and Molecular Medicine, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
JAMA ; 328(11): 1104-1107, 2022 09 20.
Article em En | MEDLINE | ID: mdl-35913747
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Viral / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Farmacorresistência Viral / Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / SARS-CoV-2 / COVID-19 / Tratamento Farmacológico da COVID-19 Tipo de estudo: Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article